🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison photos, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in users administering substances of uncertain source.

Several experts stated the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the platform has removed violative material and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Digital Marketplace Activities

Research also found groups with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or administering at home.

After moments of joining one group, a seller shared contact information, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these communities, posts display black plastic packages with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Although the research behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has already seen individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially serious medical dangers”.